US looking at joint production of Johnson and Johnson's Covid vaccine
Updated May 13, 2021 05:11 am
- The US is looking at joint production of Johnson and Johnson's Covid-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tuesday. Smith also said that the efficacy of AstraZeneca's Covid-19 vaccine manufactured at a production facility in Baltimore is not yet clear and the Food and Drug Administration has not yet certified that the doses are available for anyone's use or for export.
- Last month, the White House said that the US plans to share 60 million doses of AstraZeneca's vaccine globally as soon as they become available, and India expected a significant chunk of the total stockpile.
local_offerTags: johnson Covid vaccine united states
comment
Comments